Checkpoint Therapeutics Inc (CKPT) - Financial and Strategic SWOT Analysis Review

Checkpoint Therapeutics Inc (CKPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Checkpoint Therapeutics Inc (Checkpoint Therapeutics), a subsidiary of Fortress Biotech Inc, is a clinical-stage biopharmaceutical company that acquires, develops and commercializes novel treatments for solid tumor cancers. Its lead product candidate, CK-101 molecule is in Phase I clinical trials for treatment of patients with positive epidermal growth factor receptor (EGFR). The company’s other lead product candidate CK-301, is an anti-PD L1 antibody intended for the treatment of patients with non-small cell lung cancer (NSCLC) and other solid tumors. Its other pipeline products includes a portfolio of human immuno-oncology agents and targeted anti-cancer agents intended for the treatment of multiple types of cancer including renal cell carcinoma, EGFR mutation-positive NSCLC and multiple forms of cancer. The company also works in partnership with other pharmaceutical companies to co-develop its antibodies. Checkpoint Therapeutics is headquartered in New York, the US.

Checkpoint Therapeutics Inc Key Recent Developments

May 06,2020: Checkpoint Therapeutics reports first quarter 2020 financial results and recent corporate highlights
Mar 11,2020: Checkpoint Therapeutics reports full-Year 2019 financial results and recent corporate highlights
Nov 07,2019: Checkpoint Therapeutics reports third quarter 2019 financial results and recent corporate highlights
Aug 08,2019: Checkpoint Therapeutics reports second quarter 2019 financial results and recent corporate highlights
Jul 01,2019: Checkpoint Therapeutics added to Russell 2000 Index

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
 


Section 1 - About the Company
Checkpoint Therapeutics Inc - Key Facts
Checkpoint Therapeutics Inc - Key Employees
Checkpoint Therapeutics Inc - Key Employee Biographies
Checkpoint Therapeutics Inc - Major Products and Services
Checkpoint Therapeutics Inc - History
Checkpoint Therapeutics Inc - Company Statement
Checkpoint Therapeutics Inc - Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
Checkpoint Therapeutics Inc - Business Description
Checkpoint Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Checkpoint Therapeutics Inc - Strengths
Checkpoint Therapeutics Inc - Weaknesses
Checkpoint Therapeutics Inc - Opportunities
Checkpoint Therapeutics Inc - Threats
Checkpoint Therapeutics Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Checkpoint Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 06, 2020: Checkpoint Therapeutics reports first quarter 2020 financial results and recent corporate highlights
Mar 11, 2020: Checkpoint Therapeutics reports full-Year 2019 financial results and recent corporate highlights
Nov 07, 2019: Checkpoint Therapeutics reports third quarter 2019 financial results and recent corporate highlights
Aug 08, 2019: Checkpoint Therapeutics reports second quarter 2019 financial results and recent corporate highlights
Jul 01, 2019: Checkpoint Therapeutics added to Russell 2000 Index
May 09, 2019: Checkpoint Therapeutics reports first quarter 2019 financial results and recent corporate highlights
Mar 15, 2019: Checkpoint Therapeutics reports full-year 2018 financial results and recent corporate highlights
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
 


List Of Tables


Checkpoint Therapeutics Inc, Key Facts
Checkpoint Therapeutics Inc, Key Employees
Checkpoint Therapeutics Inc, Key Employee Biographies
Checkpoint Therapeutics Inc, Major Products and Services
Checkpoint Therapeutics Inc, History
Checkpoint Therapeutics Inc, Key Competitors
Checkpoint Therapeutics Inc, Ratios based on current share price
Checkpoint Therapeutics Inc, Annual Ratios
Checkpoint Therapeutics Inc, Annual Ratios (Cont...1)
Checkpoint Therapeutics Inc, Interim Ratios
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Checkpoint Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures


Checkpoint Therapeutics Inc, Performance Chart (2015 - 2019)
Checkpoint Therapeutics Inc, Ratio Charts
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
 


Anika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2021 Update

Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for degenerative orthopedic diseases and traumatic conditions. It offers solutions for ortho-biologics, dermal, ophthalmic, surgical and veterinary applications. Its major

USD 750 View Report

Chinook Therapeutics Inc (KDNY) - Financial and Strategic SWOT Analysis Review

Chinook Therapeutics, Inc (Chinook)., formerly Aduro BioTech Inc is a clinical-stage immunotherapy company that discovers, develops and commercializes therapies for the treatment of cancer. The company develops product candidates using

USD 300 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available